Evidence map›Paper›PMID 38051352›Full record

ReviewEuropean journal of microbiology & immunology2023

Campylobacter in Africa - A specific viewpoint.

Ellis Kobina Paintsil, Wycliffe O Masanta, Annika Dreyer, Leonid Ushanov, Stella I Smith, Hagen Frickmann, Andreas E Zautner

Abstract readReview
In one paragraph

Review in European journal of microbiology & immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Drivers of zoonoticOne health (Amsterdam, Netherlands) · 2026
    Article
  2. Observational
  3. Tropical medicine and infectious disease · 2025
    Article
  4. Vaccines · 2025
    Article
  5. Article
  6. Article
  7. Pathogens (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ellis Kobina Paintsil1Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), South-End, Asuogya Road, 039-5028 Kumasi, Ghana.
Wycliffe O Masanta3Maseno University Medical School, Department of Medical Microbiology, Private Bag, 40105 Maseno, Kenya.
Annika Dreyer4Institute for Medical Microbiology and Virology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Leonid Ushanov5Institute of Veterinary Medicine, Agricultural University of Georgia, 0159 Tbilisi, Georgia.
Stella I Smith6Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos 101212, Nigeria.
Hagen Frickmann7Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Hamburg, 20359 Hamburg, Germany.
Andreas E Zautner9Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany.ORCID 0000-0003-0984-013X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Campylobacter infections and campylobacteriosis-associated post-infectious sequelae are a significant global health burden that needs to be addressed from a specific African perspective. We conducted a comprehensive literature search on NCBI PubMed to compile a comprehensive narrative review article on Campylobacter infections in Africa, focusing on key aspects in human and veterinary medicine as well as food hygiene. We specifically focused on the epidemiology of enteropathogenic Campylobacter spp. in sub-Saharan and North Africa considering antimicrobial susceptibility. The most significant sequela resulting from molecular mimicry to Campylobacter surface structures is the Guillain-Barré syndrome, which was mainly examined in the context of limited studies conducted in African populations. A dedicated subsection is allocated to the limited research on the veterinary medically important species Campylobacter fetus. There are significant differences in the composition of the gut microbiome, especially in rural areas, which affect the colonization with Campylobacter spp. and the manifestation of campylobacteriosis. There may be a problem of overdiagnosis due to asymptomatic colonization, particularly in the detection of Campylobacter using molecular biological techniques. To reduce the colonization and infection rate of Campylobacter, we propose implementing several control measures and urge further research to improve the current understanding of the peculiarities of campylobacteriosis in Africa.

Indexed as

Africaantimicrobial susceptibilityCampylobacter coliCampylobacter fetusCampylobacter jejunicontrol measuresdiagnosticsepidemiologyGuillain-Barré syndromemicrobiome

Identifiers

PMID38051352
PMCPMC10755667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.